Pregnancy induces a wide range of physiological adaptations across multiple organ systems, all of which have significant implications for anesthetic management. These changes, which begin early in pregnancy and continue to evolve throughout gestation, are primarily driven by hormonal fluctuations, mechanical effects of the enlarging uterus, increased metabolic demands of the growing fetus, and the low-resistance placental circulation. For anesthesia providers, understanding these changes is essential to optimize both maternal and fetal outcomes during surgery, as they directly influence anesthetic drug metabolism, respiratory function, cardiovascular stability, and airway management.
One of the most profound physiological changes during pregnancy occurs within the respiratory system. The increased metabolic demands of the fetus and placenta lead to a 20% rise in maternal oxygen consumption. Simultaneously, the enlarging uterus causes a 20% decrease in pulmonary functional residual capacity (FRC), primarily due to diaphragmatic elevation. These changes contribute to a rapid decline in maternal arterial oxygen tension (PaO2) even during brief periods of apnea, making pregnant patients particularly vulnerable to hypoxemia during anesthesia induction and emergence. The risk of hypoxemia is further accentuated in women with pre-existing conditions like obesity or pre-eclampsia. Additionally, the hormonal effects of progesterone enhance brain stem sensitivity to carbon dioxide (PaCO2), leading to mild maternal hyperventilation: resting PaCO2 falls to about 30 to 32 mm Hg with a compensated respiratory alkalosis. Under controlled ventilation this pregnant value, not 40 mm Hg, is the target, because maternal hypocapnia constricts uterine vessels and shifts the oxyhemoglobin curve to the left, while hypercapnia produces fetal acidosis. While this respiratory adaptation is generally protective, it may be counterbalanced during anesthesia by increased central nervous system sensitivity to anesthetic agents, complicating ventilatory management.
Airway management poses another critical challenge due to the anatomical and physiological changes that occur during pregnancy. Hormonal influences, particularly the increased levels of estrogen, lead to swelling and increased friability of the oropharyngeal tissues, which reduce the size of the glottic opening. These changes are most pronounced in the third trimester but can be present as early as the second trimester. Studies have shown that pregnant women are at a significantly higher risk for difficult intubation. For example, research indicates that women with Mallampati class III and IV airways are 7.5 to 11.3 times more likely to experience difficult intubation compared to those with class I airways. Failed intubation occurs in roughly 1 in 300 obstetric general anesthetics, several times the rate in the general surgical population, and the airway is also harder to manage because of breast enlargement, reduced functional residual capacity, and the aspiration risk discussed below. This underscores the need for meticulous airway assessment, a smaller endotracheal tube (6.0 to 6.5 mm) ready, a video laryngoscope and a second-generation supraglottic rescue device at hand, and the presence of experienced anesthesia personnel whenever a pregnant patient receives general anesthesia.
Hemodynamic changes during pregnancy are equally significant and require careful consideration during anesthesia. Blood volume and cardiac output increase by approximately 40-50%, while systemic vascular resistance decreases due to the vasodilatory effects of progesterone and the low-resistance placental circulation. Plasma volume expands more than red cell mass, so a dilutional physiological anemia develops; the hematocrit is lowest in the late second to early third trimester (about 28 to 34 weeks), when plasma volume plateaus. Aortocaval compression by the enlarging uterus, particularly after 20 weeks of gestation, can lead to decreased venous return, hypotension, and reduced cardiac output, especially when the patient is supine or under neuraxial anesthesia. To mitigate these effects, it is essential to position the patient with left uterine displacement (a left lateral tilt of at least 15 degrees, or a wedge under the right hip) to displace the uterus away from the aorta and inferior vena cava, thereby maintaining adequate venous return and cardiac output. Because the uteroplacental bed has no autoregulation, uterine blood flow falls in step with maternal pressure; treat hypotension promptly with fluid and phenylephrine or ephedrine, both of which are safe in pregnancy.
Gastrointestinal changes during pregnancy also have important implications for anesthesia management. Although recent evidence suggests that gastric emptying is normal during pregnancy, there remains a significantly increased risk of aspiration due to decreased lower esophageal sphincter tone and increased intragastric pressure. After 20 weeks of gestation, the risk of aspiration is heightened, particularly during general anesthesia. In such cases, regional anesthesia is preferred when feasible to avoid exposing the fetus to general anesthetic agents and to minimize the risk of aspiration. However, when general anesthesia is required, careful consideration must be given to airway management, especially in patients with a history of gastroesophageal reflux disease (GERD) or obesity. Aspiration prophylaxis (a nonparticulate antacid such as sodium citrate, with an H2 blocker and metoclopramide as time allows) followed by rapid sequence induction with cricoid pressure and a cuffed endotracheal tube is the standard approach from about 18 to 20 weeks onward and in any patient with reflux symptoms; a supraglottic airway is a rescue device after failed intubation, not a first choice, once aspiration risk is raised.
